What we’ve learned
from 2 decades’ experience
with the LNG-IUS

The latest data on long-term use, benefits, and risks of the levonorgestrel-releasing intrauterine system—to fine-tune and amplify its use in your practice

Dr. Heikinheimo is Adjunct Professor of Obstetrics and Gynecology at Helsinki University Central Hospital in Helsinki, Finland.

Dr Heikinheimo has designed educational events and been a paid lecturer for Bayer Schering Pharma AG, and he belongs to its international advisory board.

With the total fertility rate in the United States at just over two children for every woman, one thing seems obvious: The “average” woman needs several decades of effective contraception during her fertile life span.¹ The situation is even more compelling in Europe, where several countries are experiencing a decline in population. Clearly, women are choosing to have smaller families, or none at all, or are postponing childbearing longer than ever before.